TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure - Adventist HealthCare

Skip to Content

Clinical Trial Details

TRANSFORM-HF

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Heart Failure
Study Type: Interventional
Phase: Phase III
Study Start Date: 07/11/2018
Study Completion Date: 08/14/2022

The purpose of the study is to compare the treatment strategy of torsemide versus furosemide on clinical outcomes over 12 months in patients with heart failure who are hospitalized.

NCT Number
TRANSFORM-HF
Principal Investigator(s)
Geetha Pinto, MD
Sponsor(s)
Duke University
Participant Eligibility
  • Age: 18 - 80
  • Gender: Male, Female

Location

  • Adventist HealthCare Shady Grove Medical Center
    9901 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6000

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 100k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!